Cargando…

Gastrostomy Tube Insertion in Pediatric Patients With Autosomal Recessive Polycystic Kidney Disease (ARPKD): Current Practice

Introduction: Autosomal recessive polycystic kidney disease (ARPKD) is a severe hepatorenal disorder of childhood. Early renal disease in ARPKD may require renal replacement therapy and is associated with failure to thrive resulting in a need for nasogastric tube feeding or gastrostomy. In ARPKD pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burgmaier, Kathrin, Brandt, Joy, Shroff, Rukshana, Witters, Peter, Weber, Lutz T., Dötsch, Jörg, Schaefer, Franz, Mekahli, Djalila, Liebau, Max C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994991/ https://www.ncbi.nlm.nih.gov/pubmed/29915780 http://dx.doi.org/10.3389/fped.2018.00164

Ejemplares similares

Clinical courses and complications of young adults with Autosomal Recessive Polycystic Kidney Disease (ARPKD)
por: Burgmaier, Kathrin, et al.
Publicado: (2019)

Severe neurological outcomes after very early bilateral nephrectomies in patients with autosomal recessive polycystic kidney disease (ARPKD)
por: Burgmaier, Kathrin, et al.
Publicado: (2020)

Clinical Characteristics and Courses of Patients With Autosomal Recessive Polycystic Kidney Disease-Mimicking Phenocopies
por: Halawi, Abdul A., et al.
Publicado: (2023)

Early childhood height-adjusted total kidney volume as a risk marker of kidney survival in ARPKD
por: Burgmaier, Kathrin, et al.
Publicado: (2021)

Occurrence of Portal Hypertension and Its Clinical Course in Patients With Molecularly Confirmed Autosomal Recessive Polycystic Kidney Disease (ARPKD)
por: Wicher, Dorota, et al.
Publicado: (2020)

Autosomal recessive polycystic kidney disease (ARPKD) in a Nigerian newborn: a case report
por: Bolaji, Olufunke, et al.
Publicado: (2018)

Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease
por: Mekahli, Djalila, et al.
Publicado: (2023)

Unmet needs and challenges for follow-up and treatment of autosomal dominant polycystic kidney disease: the paediatric perspective
por: De Rechter, Stéphanie, et al.
Publicado: (2018)

Phenotypic Variability in Siblings With Autosomal Recessive Polycystic Kidney Disease
por: Ajiri, Ramona, et al.
Publicado: (2022)

Recent Progress of the ARegPKD Registry Study on Autosomal Recessive Polycystic Kidney Disease
por: Ebner, Kathrin, et al.
Publicado: (2017)

Rationale, design and objectives of ARegPKD, a European ARPKD registry study
por: Ebner, Kathrin, et al.
Publicado: (2015)

Translational research approaches to study pediatric polycystic kidney disease
por: Liebau, Max Christoph, et al.
Publicado: (2021)

The carboxy‐terminus of the human ARPKD protein fibrocystin can control STAT3 signalling by regulating SRC‐activation
por: Dafinger, Claudia, et al.
Publicado: (2020)

The wind of change in the management of autosomal dominant polycystic kidney disease in childhood
por: Gimpel, Charlotte, et al.
Publicado: (2021)

Is Autosomal Dominant Polycystic Kidney Disease Becoming a Pediatric Disorder?
por: De Rechter, Stéphanie, et al.
Publicado: (2017)

Multi-parametric MRI of Kidney Disease Progression for Autosomal Recessive Polycystic Kidney Disease (ARPKD): Mouse Model and Initial Patient Results
por: MacAskill, Christina J., et al.
Publicado: (2020)

Early clinical management of autosomal recessive polycystic kidney disease
por: Liebau, Max Christoph
Publicado: (2021)

Clinicians’ attitude towards family planning and timing of diagnosis in autosomal dominant polycystic kidney disease
por: De Rechter, Stéphanie, et al.
Publicado: (2017)

Implications of early diagnosis of autosomal dominant polycystic kidney disease: A post hoc analysis of the TEMPO 3:4 trial
por: Janssens, Peter, et al.
Publicado: (2020)

Is There a Functional Role of Mitochondrial Dysfunction in the Pathogenesis of ARPKD?
por: Liebau, Max Christoph
Publicado: (2021)

Polycystic Kidney Disease Drug Development: A Conference Report
por: Liebau, Max C., et al.
Publicado: (2022)

Systematic review on outcomes used in clinical research on autosomal recessive polycystic kidney disease—are patient-centered outcomes our blind spot?
por: Gimpel, Charlotte, et al.
Publicado: (2021)

Atmin modulates Pkhd1 expression and may mediate Autosomal Recessive Polycystic Kidney Disease (ARPKD) through altered non-canonical Wnt/Planar Cell Polarity (PCP) signalling
por: Richards, Taylor, et al.
Publicado: (2019)

Autosomal Recessive Polycystic Kidney Disease
por: Salati, Sajad Ahmad
Publicado: (2014)

Autosomal Recessive Polycystic Kidney Disease
por: Hafer, Ashley S., et al.
Publicado: (2017)

ARPKD and early manifestations of ADPKD: the original polycystic kidney disease and phenocopies
por: Bergmann, Carsten
Publicado: (2014)

Apelin is altered in subjects with autosomal dominant polycystic kidney disease and preserved kidney function
por: Janssens, Peter, et al.
Publicado: (2023)

Leukopenia in autosomal dominant polycystic kidney disease: a single-center cohort of kidney transplant candidates with post-transplantation follow-up
por: Schellekens, Pieter, et al.
Publicado: (2023)

Autosomal recessive polycystic kidney disease diagnosed in fetus
por: Thomas, Joseph, et al.
Publicado: (2007)

Molecular Pathophysiology of Autosomal Recessive Polycystic Kidney Disease
por: Cordido, Adrian, et al.
Publicado: (2021)

Tolvaptan use in children and adolescents with autosomal dominant polycystic kidney disease: rationale and design of a two-part, randomized, double-blind, placebo-controlled trial
por: Schaefer, Franz, et al.
Publicado: (2019)

International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people
por: Gimpel, Charlotte, et al.
Publicado: (2019)

Fatal outcome of autosomal recessive polycystic kidney disease in neonates with recessive PKHD1 mutations
por: Jung, Jiwon, et al.
Publicado: (2020)

Autosomal dominant and autosomal recessive polycystic kidney disease: hypertension and secondary cardiovascular effect in children
por: Lucchetti, L., et al.
Publicado: (2023)

Enhanced MCP-1 Release in Early Autosomal Dominant Polycystic Kidney Disease
por: Janssens, Peter, et al.
Publicado: (2021)

Standardized 4-point scoring scale of [(18)F]-FDG PET/CT imaging helps in the diagnosis of renal and hepatic cyst infections in patients with autosomal dominant polycystic kidney disease: a validation cohort
por: Demuynck, Selina, et al.
Publicado: (2023)

Autosomal Recessive Polycystic Kidney Disease: Antenatal Diagnosis and Histopathological Correlation
por: Rajanna, Dayananda Kumar, et al.
Publicado: (2013)

Genetics of Autosomal Recessive Polycystic Kidney Disease and Its Differential Diagnoses
por: Bergmann, Carsten
Publicado: (2018)

Extracranial Aneurysms in 2 Patients with Autosomal Recessive Polycystic Kidney Disease
por: Elchediak, Daniel S., et al.
Publicado: (2017)

Diagnosis and Management of Hepatobiliary Complications in Autosomal Recessive Polycystic Kidney Disease
por: Wehrman, Andrew, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h0cnelp1qnmtu17691c44rjc53